8-KFiled Aug 19, 8:00 PM ET

T3 Defense Inc. Receives Nasdaq Notice for Equity Non‑Compliance

$DFNS · T3 Defense Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

T3 Defense Inc. Receives Nasdaq Notice for Equity Non‑Compliance

What Happened
T3 Defense Inc. announced that on August 20, 2026 it received a Nasdaq Listing Qualifications notice that it does not meet the minimum stockholders' equity requirement under Nasdaq Listing Rule 5450(b)(1)(A) (the $10,000,000 minimum). The company reported stockholders’ equity of negative $19,659,000 as of June 30, 2026, down from $42,523,000 as of March 31, 2026. Management attributes the decline to warrants issued in connection with a $10 million private placement in February 2026; the placement proceeds were recorded as a Common Warrant liability, and the company recorded a change-in-fair-value loss on that liability of approximately $98,958 thousand (≈ $98.96M) for the six months ended June 30, 2026 and $80,884 thousand (≈ $80.88M) for the three months ended June 30, 2026. The Common Warrant liability increased from about $25,429 thousand (≈ $25.43M) at initial recognition to $124,387 thousand (≈ $124.39M) as of June 30, 2026.

Key Details

  • Nasdaq rule: Listing Rule 5450(b)(1)(A) requires minimum stockholders' equity of $10,000,000.
  • Notice date: August 20, 2026; Company has 45 days (until October 5, 2026) to submit a plan to regain compliance.
  • If Nasdaq accepts the plan, an extension of up to 180 calendar days from the notice date may be granted to evidence compliance.
  • Trading status: The notice does not affect trading; DFNS continues to trade on Nasdaq.
  • Primary cause cited: fair‑value increases on Common Warrant liability tied to the $10M February 2026 private placement.

Why It Matters
This notice signals a material listing-risk issue: if T3 Defense cannot convince Nasdaq it will regain the required $10M equity within the allowed timeline (or via an approved plan and extension), Nasdaq could issue a delisting determination. Delisting would harm liquidity and could materially affect shareholder value. The company can appeal and request hearings to stay any delisting action, and it intends to submit a plan to regain compliance, but there is no assurance Nasdaq will accept the plan or that compliance will be achieved. Investors should note the large non‑cash GAAP losses driven by warrant fair‑value accounting that produced the equity shortfall and monitor filings for the company’s compliance plan and any updates from Nasdaq.